logo
Australia's first fixed pill testing site is opening in Melbourne

Australia's first fixed pill testing site is opening in Melbourne

Daily Telegraph17-06-2025
Don't miss out on the headlines from Lifestyle. Followed categories will be added to My News.
The lifesaving service is expected to reduce pressure on frontline services.
After successful trials at music festivals across the state, Melbourne is getting its first permanent pill testing site.
Open Thursdays to Sundays from August in the inner-north suburb of Fitzroy from August, the facility is close to nightlife, public transport, community health and social services.
According to the Victoria's Department of Health, about half of Australian adults have used drugs at some point in their lives, and there has been an increase in emergency department admissions relating to use and overdose deaths involving novel synthetic drugs.
Run by Youth Support and Advocacy Service, The Loop Australia, and Harm Reduction Victoria, the government said the site will provide a free, lifesaving service.
The results of pill testing globally
Pill testing has been proven not to encourage people to use drugs, but to provide education and information about what people are actually taking, so they can make safer, more informed decisions.
Mental Health Minister Ingrid Stitt said, "No drug is safe, but with testing and open, health-focused conversations, we are helping Victorians make more informed and safer choices".
65 per cent of service users spoke to a health professional about drug and alcohol safety and harm reduction for the first time. Image: Pexels
"Our pill testing trial has already shown young people want the information that could keep them safe and now we'll support even more Victorians with our fixed site service in Fitzroy."
During the service's trial period, almost 1400 samples were tested at five different festivals.
65 per cent of service users spoke to a health professional about drug and alcohol safety and harm reduction for the first time, and more than 30 per cent said they would take smaller amounts after these discussions.
And in the UK, police and medical services at a festival said pill testing contributed to a 95 per cent decrease in drug-related hospital admissions. Image: iStock
At a separate pill testing clinic in Canberra, one in 10 samples were discarded on-site once the service user learned what was in them.
One third of people whose sample contained a different or additional drug from what they expected, or where results were inconclusive, said they 'definitely will not use' the illicit drug.
And in the UK, police and medical services at a festival said pill testing contributed to a 95 per cent decrease in drug-related hospital admissions.
Detection of lethal contaminants. Image: Unsplash
Detection of lethal contaminants
Despite Australia not experiencing the same level of fentanyl crisis as the US, the Australian Federal Police has made significant seizures of the opioid in the last three years, suggesting it may be cut into recreational drugs.
Experts are also concerned about the growing presence of nitazenes in Australian wastewater. Canberra's CANTEST service identified a new variant with a high risk of overdose last year, which is 'one of the most potent drugs of its class ever detected.'
The government said these drugs can be detected early and rapidly assessed through testing.
The Fitzroy facility is staffed by chemists who analyse samples of substances, while trained harm reduction workers deliver test results and discuss possible risks. Image: Getty
While still dangerous, being informed about the contents of their samples can help reduce the risk of overdose for service users.
The Fitzroy facility is staffed by chemists who analyse samples of substances, while trained harm reduction workers deliver test results and discuss possible risks, service users' existing health conditions and potential interactions between drugs and prescription medications.
In addition to saving lives and reducing drug harm, the service is hoped to decrease pressure on frontline services.
Originally published as Australia's first fixed pill testing site is opening in Melbourne
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Spike in adverse event reports for ADHD medication Vyvanse
Spike in adverse event reports for ADHD medication Vyvanse

The Australian

time7 hours ago

  • The Australian

Spike in adverse event reports for ADHD medication Vyvanse

Authorities are investigating a spike in incidents involving one of Australia's most widely used ADHD medications. Adverse event reports linked to medication Vyvanse have spiked massively this year, and the manufacturer says no changes in the chemical production have been made. 'The Therapeutic Goods Administration (TGA) is currently investigating a potential safety signal associated with Vyvanse, including independent testing of the medicine through the TGA Laboratories,' a spokesperson told NewsWire. 'The investigation is the result of a recent increase in adverse event notifications relating to concerns about the quality, safety, and reduced effectiveness of the drug.' The TGA issued an alert about a typo on the Vyvanse label earlier this year. Picture: TGA 'There are no compliance signals currently under investigation for the facilities used in the manufacture of this product.' A 'signal' is detection of a pattern which requires further investigation. While not formally a pattern in the TGA's eyes, reports of adverse events such as anxiety, ineffectiveness and insomnia have increased massively this year. There have also been 88 reports of issues with the medicines label, which was flagged by the TGA earlier this year for minor typos; however, one of the typos added an extra 'S' to the word capsule; 'Each capsules contains 60mg lisdexamfetamine dimesilate'. The TGA maintains the Database of Adverse Event Notifications, where people report issues with medications. There have been 320 adverse events linked to Vyvanse in the first half of this year, compared to nine reports in the second half of 2024. Inclusion in the database does not confirm the incident is caused by the medication. Reports of ineffective Vyvanse have hit 150 so far this year, along with 88 reports of anxiety, and 73 reports that the therapeutic response has decreased. Last year, 1.8m Vyvanse prescriptions were written in Australia, excluding Department of Veterans' Affairs patients, over-the-counter drugs, private prescriptions and public inpatient prescriptions. Picture: NewsWire / Martin Ollman Prescriptions of Vyvanse have been steadily increasing for the past few years. More than 958,000 scripts were written by public system health workers in 2022, rising to 1.4 million in 2023, and then 1.8m last year, government data shows. In a statement, supplier Takeda Pharmaceuticals Australia said a change of manufacturing facility in 2024 did not alter the chemical composition of the medicine. 'There have been no changes to the formulation,' a Takeda spokesperson told the ABC. Vyvanse was produced with strict quality controls, in line with Australia's Therapeutics Goods Act, the spokesperson said. The labelling typo did not affect the quality of the medication, they said. Blair Jackson Reporter Blair's journalism career has taken him from Perth, to New Zealand, Queensland and now Melbourne. Blair Jackson

Spike in ADHD medication adverse event reports
Spike in ADHD medication adverse event reports

News.com.au

time10 hours ago

  • News.com.au

Spike in ADHD medication adverse event reports

Authorities are investigating a spike in incidents involving one of Australia's most widely used ADHD medications. Adverse event reports linked to medication Vyvanse have spiked massively this year, and the manufacturer says no changes in the chemical production have been made. 'The Therapeutic Goods Administration (TGA) is currently investigating a potential safety signal associated with Vyvanse, including independent testing of the medicine through the TGA Laboratories,' a spokesperson told NewsWire. 'The investigation is the result of a recent increase in adverse event notifications relating to concerns about the quality, safety, and reduced effectiveness of the drug.' 'There are no compliance signals currently under investigation for the facilities used in the manufacture of this product.' A 'signal' is detection of a pattern which requires further investigation. While not formally a pattern in the TGA's eyes, reports of adverse events such as anxiety, ineffectiveness and insomnia have increased massively this year. There have also been 88 reports of issues with the medicines label, which was flagged by the TGA earlier this year for minor typos; however, one of the typos added an extra 'S' to the word capsule; 'Each capsules contains 60mg lisdexamfetamine dimesilate'. The TGA maintains the Database of Adverse Event Notifications, where people report issues with medications. There have been 320 adverse events linked to Vyvanse in the first half of this year, compared to nine reports in the second half of 2024. Inclusion in the database does not confirm the incident is caused by the medication. Reports of ineffective Vyvanse have hit 150 so far this year, along with 88 reports of anxiety, and 73 reports that the therapeutic response has decreased. Prescriptions of Vyvanse have been steadily increasing for the past few years. More than 958,000 scripts were written by public system health workers in 2022, rising to 1.4 million in 2023, and then 1.8m last year, government data shows. In a statement, supplier Takeda Pharmaceuticals Australia said a change of manufacturing facility in 2024 did not alter the chemical composition of the medicine. 'There have been no changes to the formulation,' a Takeda spokesperson told the ABC. Vyvanse was produced with strict quality controls, in line with Australia's Therapeutics Goods Act, the spokesperson said. The labelling typo did not affect the quality of the medication, they said.

Measles alert issued across NT airports, tourism hotspots
Measles alert issued across NT airports, tourism hotspots

News.com.au

time12 hours ago

  • News.com.au

Measles alert issued across NT airports, tourism hotspots

Northern Territory health authorities have issued a measles alert after a man travelled through multiple tourism hotspots before ending up in hospital in north Queensland. NT Health issued the alert on Saturday morning, warning anyone who was on tourism trips in the state, at restaurant in Kakadu National Park, or travelled through Darwin or Alice Springs Airports on specific dates in July to be alert for measles symptoms. These include a fever, sore eyes, a runny nose, a cough, and a blotchy red rash. 'Check your vaccination status,' an NT Health spokesperson said. 'Measles is highly contagious but preventable with two doses of a measles-containing vaccine.' Health authorities suspect the man who travelled while infectious acquired measles in Indonesia. 'The NT Centre for Disease Control is urging Territorians to be alert following confirmation of a measles case who travelled through Darwin and Alice Springs while infectious,' the alert reads. 'The individual, likely infected overseas, visited multiple public locations in the NT between July 17 and 23.' NT Health says the man was likely infectious when he went on an all-day tour with Ethical Adventures in Litchfield National Park on July 17. The next day, he left for an overnight tour with AAPT Kings Jabiru, and was at the Mercure Kakadu Crocodile Hotel in Jabiru from 6pm to 8pm on July 18. The measles alert does not account for his movements the next two days, but the next listed location is the Museum and Art Gallery of the Northern Territory, from 1pm to 3pm on July 20. It is believed the man then went to Darwin Airport at 3.30pm and flew to Alice Springs on Qantas flight QF1960, arriving at 7pm. On Wednesday, July 23, the man flew from Alice Springs to Cairns on Air North flight TL361. 'Anyone who attended these locations during these times should monitor for symptoms … Symptoms can take up to 18 days after exposure to develop,' the alert said. 'The vaccine is safe and effective, and available from your GP, local health centre, Aboriginal health clinic, and vaccinating pharmacies.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store